AAPM July 31 - August 3, 2016 Washington, DC
National Proton Conference March 6 – 9, 2017 Orlando, FL
Radiance 330® Proton Therapy System to be installed at Massachusetts General Hospital Flower Mound, Texas USA ProTom International (ProTom) is accelerating its focus on the installation of the company’s Radiance 330® Proton Therapy System (Radiance 330) in the Massachusetts General Hospital (MGH) Department of Radiation Oncology. As the hospital’s new proton therapy center is being installed [...]
Radiance 330® Proton Therapy System to be installed at Massachusetts General Hospital Flower Mound, Texas USA -- ProTom International ("ProTom") is pleased to announce the execution of a purchase agreement with Massachusetts General Hospital ("MGH") for the acquisition of a Radiance 330® Proton Therapy System ("Radiance 330") to be housed in the MGH Department of [...]
ProTom International, the developer and manufacturer of a technologically advanced proton beam radiation therapy system, announced today it has received 510(k) clearance for its Radiance 330 Proton Therapy System. The Radiance 330 is a compact, modular and more affordable proton beam delivery system for the treatment of patients with cancer. The system delivers extremely focused, [...]
COMPACT PROTON THERAPY TECHNOLOGY ACHIEVES SCHEDULED DECEMBER 2012 MILESTONE OF BEAM AT GANTRY ROOM ISOCENTER
PRESS RELEASE December 12, 2012 Flower Mound, Texas/Flint, Michigan, USA — Testing of a compact cancer-treatment technology from ProTom International (“ProTom”) demonstrated last week that the system achieves its design specification: delivering high-energy protons to isocenter at a beam intensity sufficient for standard clinical practice. The ProTom technical team measured stable and reproducible performance on [...]
Flower Mound, Texas-based BioTech startup ProTom International has received FDA 510(k) Clearance for its Radiance 330 ® Proton Therapy System. This clearance, officially making Radiance 330 ® commercially available, was instrumental in ProTom being awarded two new system orders — one at Massachusetts General Hospital (MGH), Boston and another at Atlantic Health System, New Jersey.